These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37313689)

  • 1. Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active-duty service members and veterans.
    Mayer CL; Savage PJ; Engle CK; Groh SS; Shofer JB; Hargrove AM; Williams TJ; Poupore EL; Hart KL; Riechers RG; Ruff RL; Peskind ER; Raskind MA
    Headache; 2023 Jun; 63(6):751-762. PubMed ID: 37313689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
    Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
    N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study.
    Zirovich MD; Pangarkar SS; Manh C; Chen L; Vangala S; Elashoff DA; Izuchukwu IS
    Mil Med; 2021 May; 186(5-6):493-499. PubMed ID: 33241323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
    Simpson TL; Saxon AJ; Meredith CW; Malte CA; McBride B; Ferguson LC; Gross CA; Hart KL; Raskind M
    Alcohol Clin Exp Res; 2009 Feb; 33(2):255-63. PubMed ID: 18945226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled clinical trial of prazosin for alcohol use disorder in active duty soldiers: Predictive effects of elevated cardiovascular parameters.
    Raskind MA; Williams T; Holmes H; Hart K; Crews L; Poupore EL; Thomas RG; Darnell J; Daniels C; Goke K; Hendrickson R; Terry G; Mayer C; Simpson T; Saxon A; Rasmussen D; Peskind ER
    Alcohol Clin Exp Res (Hoboken); 2023 Feb; 47(2):348-360. PubMed ID: 36809662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
    Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
    Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study.
    Ashina H; Iljazi A; Al-Khazali HM; Eigenbrodt AK; Larsen EL; Andersen AM; Hansen KJ; Bräuner KB; Mørch-Jessen T; Chaudhry B; Antic S; Christensen CE; Ashina M; Amin FM; Schytz HW
    J Headache Pain; 2020 Jun; 21(1):62. PubMed ID: 32493206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
    Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME
    Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Persistent Post-Traumatic Headache and Post-Concussion Symptoms Using Repetitive Transcranial Magnetic Stimulation: A Pilot, Double-Blind, Randomized Controlled Trial.
    Stilling J; Paxman E; Mercier L; Gan LS; Wang M; Amoozegar F; Dukelow SP; Monchi O; Debert C
    J Neurotrauma; 2020 Jan; 37(2):312-323. PubMed ID: 31530227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
    Aurora SK; Dodick DW; Diener HC; DeGryse RE; Turkel CC; Lipton RB; Silberstein SD
    Acta Neurol Scand; 2014 Jan; 129(1):61-70. PubMed ID: 24107267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion.
    Scott BR; Uomoto JM; Barry ES
    Headache; 2020 Mar; 60(3):526-541. PubMed ID: 31898813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving sleep: initial headache treatment in OIF/OEF veterans with blast-induced mild traumatic brain injury.
    Ruff RL; Ruff SS; Wang XF
    J Rehabil Res Dev; 2009; 46(9):1071-84. PubMed ID: 20437313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trial.
    Simpson TL; Achtmeyer C; Batten L; Reoux J; Shofer J; Peskind ER; Saxon AJ; Raskind MA
    Alcohol Alcohol; 2024 Jul; 59(5):. PubMed ID: 39270736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.